Literature DB >> 6825584

[Endocrine orbitopathy. Results of therapy in patients with reference to new pathogenetic aspects].

F A Horster, W Wildmeister.   

Abstract

Present available conservative methods of treatment were evaluated in 148 patients with euthyroid endocrine ophthalmopathy. Levothyroxine was used as the basic drug in confirming normal thyroid function after goitre operation or radio-iodine therapy. In addition, prednisone was used, at first in a massive single dose and then alternating daily. Retrobulbar X-radiation was additionally given to 21 patients. Besides, 47 patients also received a lymphokinetic drug (Venalot-Depot) assuming the endocrine eye symptoms are manifestations of "local myxoedema". No single drug was found to be superior to any of the others but a combination can be successful as long as the period between manifestation of the eye symptoms and onset of treatment has not been more than two years.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825584     DOI: 10.1055/s-2008-1069569

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Long-term observation of endocrine ophthalmopathy and retrospective appraisal of therapeutic measures.

Authors:  G Kahaly; H Böckmann; J Beyer; S Bischoff
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

2.  [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; G Gusek-Schneider; S Barth; J Hensen; F Wolf; G O Naumann; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.